President and CEO
US Neurosurgery Associates
Wayzata, Minnesota, United States
Uzma Samadani, MD PhD is a private-practice neurosurgeon and President and CEO of US Neurosurgery Assoicates. She is a 6-time “Top Doctor in Neurosurgery” in Minneapolis and Minnesota. She is also an Associate Professor in the Dept of Bioinformatics and Computational Biology at the Univ of Minnesota, and staff neurosurgeon at the Minneapolis VAHCS. She founded the neurodiagnostic start-up Oculogica Inc, which has developed the first baseline free concussion diagnostic cleared for marketing approval by the FDA, and holds multiple patents related to brain injury, its treatment and consequences.
She has been named one of the “Most Creative People in Business” by Fast Company magazine. She is on the Executive Committee of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Neurotrauma and Critical Care and served as Scientific Program Chair for their meeting in conjunction with the National Neurotrauma Society from 2014-7. She also served as Board Chair of ThinkFirst Foundation from 2019 to 2021. She is past Chair of the Minnesota State Traumatic Brain and Spinal Cord Injury Research Program and a Past-President of Women in Neurosurgery. She serves on the council of the G4 Alliance.
She has received more than $6M in research grants from national and international funding agencies to study diagnostics, risks, outcomes and treatments for brain injury. These include the United States Veterans Administration, Department of Defense, National Space and Biomedical Research Institute, Abbott Diagnostic Laboratories, American College of Surgeons, American Association of Neurological Surgeons, Thrasher Research Fund, Integra, the Steven and Alexandra Cohen Foundation and several other organizations.
She is certified by the American Board of Neurological Surgeons and a fellow of the American College of Surgeons and American Association of Neurological Surgeons.
Her research on brain injury has been discussed in the New York Times, LeMonde, LeFigaro, Wired, Washington Post, Sports Illustrated, Forbes, and Minneapolis Star Tribune as well as numerous other media sources. She has been a speaker at TedMed, the North American Brain Injury Society, National Neurotrauma Society, American Association of Neurological Surgeons meeting and multiple other conferences. She has published 70 peer-reviewed scientific papers and an additional 30 reviews and chapters including in the Journal of Neurotrauma, JAMA Neurology, Journal of Neurosurgery and the New England Journal of Medicine. Dr. Samadani has also served as an unaffiliated neurotrauma consultant to the National Football League.
(NC5503) Discussion of Ongoing and Upcoming Trials in Neurotrauma/neurocritical Care
Monday, April 24, 2023
10:45am – 11:19am PST
Disclosure(s): Abbott Laboratories: Research Grant (Ongoing); Integra Life Sciences: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Medtronic: Research Grant (Ongoing); Oculogica: Board Member/Officer/Trustee (Ongoing), Ownership Interest (Ongoing), Ownership or Partnership (Ongoing), Royalty Recipient (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)